Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry

Breast Cancer Research and Treatment

Volumn 134, Issue 3, 2012, Pages 1209-1220

  Work, Meghan E ^a   Andrulis, Irene L ^b   John, Esther M ^c,d   Hopper, John L ^e   Liao, Yuyan ^a   Zhang, Fang Fang ^a   Knight, Julia A ^f,g   West, Dee W ^c,d   Milne, Roger L ^e   Giles, Graham G ^e,h   Longacre, Teri A ^d   O'Malley, Frances ^i,j   Mulligan, Anna Marie ^i,j   Southey, Melissa C ^a,e   Hibshoosh, Hanina ^a,k   Terry, Mary Beth ^a,k  

^a Department of Medicine   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^d STANFORD CANCER INSTITUTE   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h CANCER EPIDEMIOLOGY CENTRE   (Australia)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k NONE   (United States)

more..

Author keywords

Centralized pathology; Epidemiology; Medullary breast cancer; Mucinous breast cancer; Oral contraceptives; Parity

Indexed keywords

BRCA1 PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER REGISTRY; CANCER RISK; CHILD; CLINICAL EVALUATION; COLLOID CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MENARCHE; MUTATION RATE; NULLIPARA; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 84868197841     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2056-y     Document Type: Article

References (39)

1. Wohlfahrt J, Mouridsen H, Andersen PK, Melbye M (1999) Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer 81(1):49-55
2. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR (2003) Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer 107(4):647-651
3. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR (2003) The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiol Biomarkers Prev 12(10):1061-1066
4. Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR (2003) Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control 14(3):225-233
5. Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS et al (2005) Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 93(3):364-371
6. Rosenberg LU, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman PW (2006) Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study. Breast Cancer Res 8(1):R11
7. Reeves GK, Beral V, Green J, Gathani T, Bull D (2006) Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 7(11):910-918
8. Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT et al (2006) Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 15(5):946-954
9. Garcia-Closas M, Brinton LA, Lissowska J, Chatterjee N, Peplonska B, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Blair A, Kalaylioglu Z, Rymkiewicz G et al (2006) Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 95(1):123-129
10. Li CI, Littman AJ, White E (2007) Relationship between age maximum height is attained, age at menarche, and age at first fullterm birth and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(10):2144-2149
11. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G, Burkman RT, Folger SG et al (2008) Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 167(2):230-239
12. Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR (2008) Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 17(1):43-50
13. Nyante SJ, Gammon MD, Malone KE, Daling JR, Brinton LA (2008) The association between oral contraceptive use and lobular and ductal breast cancer in young women. Int J Cancer 122(4):936-941
14. Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiol Biomarkers Prev 17(12):3427-3434
15. Reeves GK, Pirie K, Green J, Bull D, Beral V (2009) Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer 100(3):538-544
16. Anderson WF, Chu KC, Chang S, Sherman ME (2004) Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 13(7):1128-1135
17. Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9):1046-1052
18. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM (1999) Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 17(5):1442-1448
19. Louwman MW, Vriezen M, Van Beek MW, Nolthenius-Puylaert MC, Van Der Sangen MJ, Roumen RM, Kiemeney LA, Coebergh JW (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121(1):127-135
20. Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon A, Federico M, Gafa L, Grosclaude P et al (2004) Prognostic value of morphology and hormone receptor status in breast cancer-a population-based study. Br J Cancer 91(7):1263-1268
21. Armes JE, Egan AJ, Southey MC, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ (1998) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer 83(11):2335-2345
22. Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, Fiche M, Figueiro P, Maisongrosse V, Ledoussal V, Martinez Penuela J, Udvarhely N et al (2005) Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 207(3):260-268
23. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS et al (2007) Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-531
24. Rakha EA, Lee AH, Evans AJ, Menon S, Assad NY, Hodi Z, Macmillan D, Blamey RW, Ellis IO (2010) Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol 28(1):99-104
25. Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML, Brannstrom T, Bruner JM, Burger PC, Collins VP, Inskip PD, Kruchko C, McCarthy BJ et al (2008) Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 17(3):484-489
26. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone KE, Strom BL, Ursin G, Marchbanks PA, McDonald JA, Spirtas R et al (2009) Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev 18(8):2214-2220
27. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB et al (2004) The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6(4):R375-R389
28. Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ, Giles GG, Ziogas A, Andrulis IL, Whittemore AS, Hopper JL (2006) An inverse association between ovarian cysts and breast cancer in the Breast Cancer Family Registry. Int J Cancer 118(1):197-202
29. Milne RL, John EM, Knight JA, Dite GS, Southey MC, Giles GG, Apicella C, West DW, Andrulis IL, Whittemore AS, Hopper JL (2011) The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry. Int J Epidemiol 40(5):1342-1354
30. Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ, Carter BA, Catelano E, Hendrickson MR, Hibshoosh H, Layfield LJ, Memeo L, Wu H et al (2006) Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI Breast Cancer Family Registry study. Mod Pathol 19(2):195-207
31. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C et al (2007) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123-139
32. Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, Hunt KK, Hortobagyi GN, Pusztai L, Symmans WF (2010) Higher parity and shorter breastfeeding duration: association with triplenegative phenotype of breast cancer. Cancer 116(21):4933-4943
33. Lara-Medina FP-SV, Saavedra-Perez D, Blake-Cerda M, Arce C, Motola-Kuba D, Villarreal-Garza C, Gonzalez-Angulo AM, Bargallo E, Aquilar JL, Mohar A, Arrieta O (2011) Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 117(16):3658-3669
34. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R et al (2010) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 103(3):250-263
35. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI (2010) Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 22(3):399-405
36. Albrektsen G, Heuch I, Thoresen SO (2010) Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. BMC Cancer 10:226
37. Maiti B, Kundranda MN, Spiro TP, Daw HA (2009) The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121(2):479-483
38. Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, Blanchard RA, Lee JC, King TC, Rosenberg CL (2009) Triplenegative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res 11(2):R18
39. Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, Scholtens D, Khan SA (2012) Association between recency of last pregnancy and biologic subtype of breast cancers. Ann Surg Oncol 19(4):1167-1173